Proteasomal degradation of the Fox01 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins

被引:176
作者
Aoki, M
Hao, J
Vogt, PK
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan
关键词
phosphoinositide; 3-kinase; oncogenic transformation; transcriptional repression;
D O I
10.1073/pnas.0405454101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The P3k oncoprotein [homolog of the catalytic subunit p110alpha of class 1A phosphoinositicle 3-kinase (PI3K)] and its downstream effector Akt induce oncogenic transformation in cultures of chicken embryo fibroblasts (CEF). The winged helix transcription factor FoxO1 is a growth-attenuating and proapoptotic protein and serves as a substrate of Akt. Here we show that FoxO1 expression is constitutively suppressed in CEF transformed by P3k or Akt. The FoxO1 protein level is high in serum-starved normal CEF, but plate let-derived growth factor treatment induces rapid phosphorylation and disappearance of FoxO1. PI3K inhibitors or the proteasome inhibitor lactacystin interfere with this process. These data suggest that phosphorylation-dependent degradation of FoxO1 by means of proteasomes plays a role in oncogenic transformation by P3k and Akt. A dominant negative mutant of FoxO1 containing the repressor domain of the Drosophila Engrailed protein induces partial oncogenic transformation of CEF and interferes with FoxO1-dependent transcriptional activation. The FoxG1 oncoprotein also inhibits transcriptional activation by FoxO1. Inhibition of FoxO1, albeit by different mechanisms, appears to be a common denominator of the PI3K and FoxG1 oncogenic pathways.
引用
收藏
页码:13613 / 13617
页数:5
相关论文
共 45 条
[1]   FoxOs at the crossroads of cellular metabolism, differentiation, and transformation [J].
Accili, D ;
Arden, KC .
CELL, 2004, 117 (04) :421-426
[2]   Excess FoxG1 causes overgrowth of the neural tube [J].
Ahlgren, S ;
Vogt, P ;
Bronner-Fraser, M .
JOURNAL OF NEUROBIOLOGY, 2003, 57 (03) :337-349
[3]   Mechanism of activation and function of protein kinase B [J].
Alessi, DR ;
Cohen, P .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) :55-62
[4]   The Akt kinase:: Molecular determinants of oncogenicity [J].
Aoki, M ;
Batista, O ;
Bellacosa, A ;
Tsichlis, P ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14950-14955
[5]  
Aoki M, 2004, Curr Top Microbiol Immunol, V279, P321
[6]   A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt [J].
Aoki, M ;
Blazek, E ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :136-141
[7]   The catalytic subunit of phosphoinositide 3-kinase: Requirements for oncogenicity [J].
Aoki, M ;
Schetter, C ;
Himly, M ;
Batista, O ;
Chang, HW ;
Vogt, PK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) :6267-6275
[8]   Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1 [J].
Biggs, WH ;
Meisenhelder, J ;
Hunter, T ;
Cavenee, WK ;
Arden, KC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7421-7426
[9]   Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins [J].
Bouchard, C ;
Marquardt, J ;
Brás, A ;
Medema, RH ;
Eilers, M .
EMBO JOURNAL, 2004, 23 (14) :2830-2840
[10]   14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport [J].
Brunet, A ;
Kanai, F ;
Stehn, J ;
Xu, J ;
Sarbassova, D ;
Frangioni, JV ;
Dalal, SN ;
DeCaprio, JA ;
Greenberg, ME ;
Yaffe, MB .
JOURNAL OF CELL BIOLOGY, 2002, 156 (05) :817-828